Mark Kay

Mark Kay MD, PhD is a highly accomplished medical professional and academic, currently serving as Founder, Scientific Advisory Board (SAB) member, and Board of Directors (BOD) member at LogicBio Therapeutics since November 2015. In addition, Mark Kay holds the position of Scientific Founder and SAB member at Voyager Therapeutics since January 2014. Mark Kay has been a Professor at Stanford University School of Medicine since March 1998 and continues to contribute to the field as a Professor at Stanford University. Previously, Mark Kay was an Associate Professor at the University of Washington School of Medicine from 1993 to 1998. Mark Kay's educational background includes a BS in Physical Sciences from Michigan State University, an MD and PhD in Developmental Genetics from Case Western Reserve University School of Medicine, and extensive training in Pediatrics and Medical Genetics at Baylor College of Medicine.